| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 10/01/1992 | WO1992016240A1 Debridement of bodily cavities using debridement fluids |
| 10/01/1992 | WO1992016232A1 Polysaccharide-protein conjugates |
| 10/01/1992 | WO1992016231A1 HERPES SIMPLEX VACCINE COMPRISING HSV GLYCOPROTEIN gD AND 3 dEACYLATED MONOPHOSPHORYL LIPID A |
| 10/01/1992 | WO1992016212A1 Increasing the therapeutic efficiency of macrophage-targeted therapeutic agents by up-regulating the mannose lectin on macrophages |
| 10/01/1992 | WO1992016210A1 Novel liquid compositions based on derivatives of 1,4 substituted piperidine |
| 10/01/1992 | WO1992016203A1 Palytoxin-related prodrugs and a method for their administration |
| 10/01/1992 | WO1992016196A1 A composition comprising a peptide for nasal administration |
| 10/01/1992 | WO1992016184A1 Fat compositions and their use in cosmetic and pharmaceutical emulsion products |
| 10/01/1992 | WO1992016182A2 Method for inactivating enveloped viruses and sperm |
| 10/01/1992 | WO1992004048A3 Inhibition of metastasis potential and invasiveness by oligosaccharides or oligosaccharide antigens or antibodies |
| 10/01/1992 | DE4110410A1 New conjugates of poly:cation and protein |
| 10/01/1992 | DE4110409A1 Neue protein-polykation-konjugate New protein-polycation conjugates |
| 10/01/1992 | CA2064288A1 Emulsifiers for the preparation of oil-in-water emulsions of ethereal oils usable in cosmetics and medicine |
| 09/30/1992 | WO1992017570A1 Virus inactivation method and pharmaceutical composition therefor |
| 09/30/1992 | WO1992017185A1 Targeted drug delivery via mixed phosphate derivatives |
| 09/30/1992 | EP0506563A1 Suspension containing alginic acid |
| 09/30/1992 | EP0506207A2 Pharmaceutical vehicles for reducing transdermal flux |
| 09/30/1992 | EP0506197A1 Topical preparation containing a suspension of solid lipid particles |
| 09/30/1992 | EP0506124A1 Methods and substances for recruiting therapeutic agents to solid issues comprising two single chain VH-VL bifunctional binding molecules |
| 09/30/1992 | EP0505966A1 Long-acting biodegradable microparticles and process for preparation |
| 09/30/1992 | EP0505872A1 Swallable tablet with a high content of edible organic acid salts |
| 09/30/1992 | EP0505566A1 Biospecific antibody to cancer cell and enzyme with prodrug-activating characteristics |
| 09/30/1992 | EP0505357A1 Method for antibody targeting of diagnostic or therapeutic agents |
| 09/30/1992 | CN1064813A Methods and compositions for treatment and repair of defects or lesions in cartilage |
| 09/30/1992 | CN1064810A Low dose dry pharmaceutical preparations |
| 09/30/1992 | CN1018452B Process for preparing azacycloalkane derivatives |
| 09/30/1992 | CA2108041A1 Targeted drug delivery via mixed phosphate derivatives |
| 09/30/1992 | CA2107092A1 Virus inactivation method and pharmaceutical composition therefor |
| 09/29/1992 | US5151499 Virus deactivated protein from plasma |
| 09/29/1992 | US5151434 Controlled-release composition and the preparation thereof |
| 09/29/1992 | US5151433 Stabilized medicinal substances, a process for the preparation thereof, and stable medicinal formulations |
| 09/29/1992 | US5151412 Pharmaceutically active conjugates having improved body tissue binding specificity |
| 09/29/1992 | US5151273 Delayed-release pharmaceutical preparation |
| 09/29/1992 | US5151272 Method of preparing controlled-release preparations for biologically active materials and resulting compositions |
| 09/29/1992 | US5151270 Self-emulsifiable dermatologic cream |
| 09/29/1992 | US5151269 Cosmetics or drugs in a nonionic surfactant |
| 09/29/1992 | US5151266 Incubation an immunoreactive component with an anionic detergent and bonding, separation |
| 09/29/1992 | US5151265 Gamma interferon formulation |
| 09/29/1992 | US5151264 Particulate vector useful in particular for the transport of molecules with biological activity and process for its preparation |
| 09/29/1992 | CA2107106A1 Cross-linking agent |
| 09/29/1992 | CA1308116C Triglyceride quaternary ammonium compounds, their preparation and use |
| 09/29/1992 | CA1308033C Injectable soft tissue augmentation materials from the placenta and their method of manufacture |
| 09/29/1992 | CA1308027C Stable prostaglandin-containing composition |
| 09/29/1992 | CA1308026C Control release composition containing zidovudine |
| 09/29/1992 | CA1308025C Phospholipid composition |
| 09/26/1992 | CA2052164A1 Lipid membrance structures for oral administration |
| 09/23/1992 | WO1992016195A1 Novel encapsulated materials |
| 09/23/1992 | EP0504919A2 Mirabilis jalapa antiviral protein |
| 09/23/1992 | EP0504483A1 Rectal compositions containing lyophilized calcitonin |
| 09/23/1992 | EP0504403A1 Topical therapeutic preparation |
| 09/23/1992 | EP0504327A1 Therapeutic uses of the hypervariable region of monoclonal antibody m195 and constructs thereof |
| 09/23/1992 | EP0504136A1 Tolerogenic immunoglobulin-protein conjugates |
| 09/22/1992 | US5149860 Carbamate derivatives |
| 09/22/1992 | US5149794 Covalent lipid-drug conjugates for drug targeting |
| 09/22/1992 | US5149782 Macromolecular drug linked to hydrophobic membrane blending agent for insertion; cleavably linked blocking agent |
| 09/22/1992 | US5149775 Method for purifying high molecular weight vinylpyridine/styrene polymers from solution |
| 09/22/1992 | US5149719 Composition for transdermal penetration of medicaments |
| 09/22/1992 | US5149708 Photosensitizing Diels-Alder porphyrin derivatives |
| 09/22/1992 | US5149543 Ionically cross-linked polymeric microcapsules |
| 09/22/1992 | US5149542 Coating membrane and compositions prepared therefrom |
| 09/22/1992 | US5149540 Hemostatic agents |
| 09/22/1992 | US5149537 Suppository form; reducing calcium levels in blood; taurocholic acid as enhancer for calcitonin |
| 09/22/1992 | US5149528 Cytotoxic protein from Trichosanthes kirilowii |
| 09/22/1992 | US5149523 Polystyrenesulfonate-drug complex and solid dosage forms thereof |
| 09/22/1992 | CA1307737C Use of antibody/antigen interactions entities to protect or modulatebiological activity |
| 09/21/1992 | WO1992016237A1 Composition for relieving skin irritation and external preparation for percutaneous adminstration containing the same |
| 09/21/1992 | CA2082947A1 Skin irritation mitigating composition and percutaneous external preparation containing same |
| 09/20/1992 | WO1992016236A1 Compositions and method comprising aminoalcohol derivatives as membrane penetration enhancers |
| 09/20/1992 | CA2106483A1 Compositions and method comprising aminoalcohol derivatives as membrane penetration enhancers |
| 09/19/1992 | WO1992016555A1 Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers |
| 09/19/1992 | CA2101918A1 Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers |
| 09/17/1992 | WO1992015676A1 Somatic cell gene therapy |
| 09/17/1992 | WO1992015614A1 Method for the stabilization of methionine-containing polypeptides |
| 09/17/1992 | WO1992015327A1 Recombinant double chain immunotoxins |
| 09/17/1992 | WO1992015326A1 Targeting complex mediated immunogenicity |
| 09/17/1992 | WO1992015324A1 Preparation of factor ix |
| 09/17/1992 | WO1992015318A1 Use of cell surface receptor targeted molecules for the treatment of viral diseases |
| 09/17/1992 | WO1992015299A1 Topical treatment of acne |
| 09/17/1992 | WO1992015291A1 Pharmaceutical preparations for the therapy of tumors containing colchicine as the active principle and methods for the use of the same |
| 09/17/1992 | WO1992015285A1 Starch-based controlled release compositions |
| 09/17/1992 | WO1992015281A1 Pharmaceutical composition for the treatment of kaposi's sarcoma |
| 09/17/1992 | WO1992013072A3 Process for the synthesis and purification of human ciliary neuronotrophic factor (cntf) from escherichia coli |
| 09/17/1992 | DE4108372A1 Asbestos-free talc hydrothermal synthesis - from silica, magnesium chloride and caustic soda, used in cosmetics and pharmaceutical industry |
| 09/17/1992 | CA2104958A1 Use of cell surface receptor targeted molecules for the treatment of viral diseases |
| 09/17/1992 | CA2086259A1 Topical treatment of acne |
| 09/16/1992 | WO1992016221A1 Pegylation of polypeptides |
| 09/16/1992 | EP0504112A2 Pharmaceutical aerosol formulations |
| 09/16/1992 | EP0503988A1 Compositions to treat onychomycoses |
| 09/16/1992 | EP0503853A2 Water soluble polymeric thickeners for products for topical application |
| 09/16/1992 | EP0503741A1 Conjugate of azidothymidine and human albumin, process for its preparation and pharmaceutical compositions containing it |
| 09/16/1992 | EP0503583A1 Composition for sustained release of erythropoietin |
| 09/16/1992 | EP0503538A1 Medicinal composition containing an anthelmintic cyclic depsipeptide |
| 09/16/1992 | EP0503521A1 Low dose dry pharmaceutical preparations |
| 09/16/1992 | EP0503440A1 Compositions containing sumatriptan |
| 09/16/1992 | EP0503301A2 Peptide derivatives and application thereof |
| 09/16/1992 | EP0502962A1 Hirudine polyalkylene glycol conjugates. |
| 09/16/1992 | EP0502949A1 Homologous guluronic acid alginate coating composition for in-vivo application and implantation and method of using same |
| 09/16/1992 | EP0502927A1 Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor |
| 09/16/1992 | EP0471792A4 Methods, reagents and test kits for determination of subpopulations of biological entities |
| 09/16/1992 | EP0470128A4 Active carbonates of polyalkylene oxides for modification of polypeptides |